We are live on ! Find out more
WIC

WealthBridge Investment Counsel Portfolio holdings

AUM $375M
1-Year Est. Return 37.9%
This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+37.9%
3 Year Est. Return
+92.55%
5 Year Est. Return
+98.97%
10 Year Est. Return
AUM
$229M
AUM Growth
+$38.7M
Cap. Flow
+$16.6M
Cap. Flow %
7.24%
Top 10 Hldgs %
40.05%
Holding
49
New
9
Increased
29
Reduced
11
Closed

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$928K
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$408K
3
INTC icon
Intel
INTC
+$206K
4
MET icon
MetLife
MET
+$149K
5
MRK icon
Merck
MRK
+$143K

Sector Composition

Rank Sector Weight
1 Healthcare 25.61%
2 Financials 18.56%
3 Industrials 13.62%
4 Technology 10.01%
5 Consumer Discretionary 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$938B
$10.2M 4.44%
75,741
+440
+0.6% +$55.8K
EFA icon
2
iShares MSCI EAFE ETF
EFA
$78.2B
$10.2M 4.44%
154,730
-6,515
-4% -$408K
MRK icon
3
Merck
MRK
$315B
$9.84M 4.3%
88,650
-1,400
-2% -$143K
EEM icon
4
iShares MSCI Emerging Markets ETF
EEM
$28.7B
$9.79M 4.28%
258,370
-25,150
-9% -$928K
V icon
5
Visa
V
$684B
$9.16M 4.01%
44,079
+1,073
+2% +$216K
GS icon
6
Goldman Sachs
GS
$300B
$9.12M 3.99%
26,565
-140
-0.5% -$48.7K
AAPL icon
7
Apple
AAPL
$4.48T
$8.67M 3.79%
66,710
+5,112
+8% +$731K
MET icon
8
MetLife
MET
$62B
$8.66M 3.79%
119,725
-2,075
-2% -$149K
LH icon
9
Labcorp
LH
$25B
$8.24M 3.6%
40,712
-175
-0.4% -$34.2K
ETN icon
10
Eaton
ETN
$167B
$7.79M 3.41%
49,620
-235
-0.5% -$36K
CVS icon
11
CVS Health
CVS
$134B
$7.66M 3.35%
82,173
+2,065
+3% +$199K
ORCL icon
12
Oracle
ORCL
$397B
$7.43M 3.25%
90,853
+3,712
+4% +$282K
SBUX icon
13
Starbucks
SBUX
$120B
$7.25M 3.17%
73,125
+2,060
+3% +$194K
GILD icon
14
Gilead Sciences
GILD
$162B
$6.79M 2.97%
79,055
+1,700
+2% +$135K
ABT icon
15
Abbott
ABT
$185B
$6.75M 2.95%
61,495
+1,475
+2% +$153K
NOC icon
16
Northrop Grumman
NOC
$77.8B
$6.31M 2.76%
11,565
-65
-0.6% -$33.9K
STZ icon
17
Constellation Brands
STZ
$22.5B
$6.08M 2.66%
26,245
+950
+4% +$227K
VGK icon
18
Vanguard FTSE Europe ETF
VGK
$30.8B
$5.95M 2.6%
107,285
+1,550
+1% +$81.8K
MDT icon
19
Medtronic
MDT
$110B
$5.72M 2.5%
73,660
+3,000
+4% +$243K
ABBV icon
20
AbbVie
ABBV
$434B
$5.55M 2.43%
34,344
+1,188
+4% +$182K
FDX icon
21
FedEx
FDX
$72.9B
$5.47M 2.39%
31,568
+1,713
+6% +$285K
DIS icon
22
Walt Disney
DIS
$170B
$5.43M 2.37%
62,471
+3,235
+5% +$309K
C icon
23
Citigroup
C
$222B
$5.12M 2.24%
113,284
+17,625
+18% +$801K
VZ icon
24
Verizon
VZ
$197B
$5.07M 2.22%
128,603
+16,275
+14% +$613K
TMO icon
25
Thermo Fisher Scientific
TMO
$214B
$4.88M 2.13%
8,855
+728
+9% +$386K

Similar funds

WealthBridge Investment Counsel's Q4 2022 Portfolio in Review

As of Q4 2022, WealthBridge Investment Counsel held 49 positions worth $229M, up 20% from $190M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

WealthBridge Investment Counsel deployed $16.6M of net new capital in Q4 2022, opening 9 new positions and adding to 29 existing holdings. Its largest new stake was Commercial Metals: 72,118 shares worth $3.48M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $928K trimmed.

  • WealthBridge Investment Counsel's largest Q4 2022 buy was Commercial Metals: 72,118 shares worth $3.48M.
  • WealthBridge Investment Counsel added most to Vanguard FTSE Emerging Markets ETF in Q4 2022, an estimated $1.5M increase.
  • WealthBridge Investment Counsel's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $928K.
  • WealthBridge Investment Counsel's ten largest holdings make up 40% of its $229M portfolio in Q4 2022.
  • WealthBridge Investment Counsel opened 9 new positions and closed 0 in Q4 2022.
  • WealthBridge Investment Counsel's portfolio value rose 20% quarter-over-quarter to $229M.

Based on WealthBridge Investment Counsel's 13F filing for Q4 2022, filed 2 Feb 2023.